RPRX

Royalty Pharma plc

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$48.57

Market Cap

$20.81B

Beta

0.42

P/E

26.2

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+5.06%

EPS Growth (YoY)+9.82%

Revenue CAGR 3Y+2.06%

P/E Ratio26.2

PEG Ratio2.76

FCF Yield+11.97%

Debt / Equity1.38

Interest Coverage5.1x

No credit card required

Already have an account? Sign in to view the full analysis for RPRX.